Search Within

Mary E Warren

Formats
  1. Journal Article (4)
  2. Meeting Abstract (4)
Groups
  1. Department of Medicine (7)
  2. Solid Tumor Oncology Division (6)
  3. Genitourinary Oncology Service (5)
  4. Biostatistics Service (4)
  5. Epidemiology and Biostatistics (4)
  6. Body Imaging Service (2)

More Groups

People
  1. Howard Scher (5)
  2. William Kelly (4)
  3. Glenn Heller (3)
  4. Kathleen Beekman (2)
  5. Lawrence Schwartz (2)
  6. Mark Fleming (2)

More People

Years
  1. 2022 (1)
  2. 2015 (1)
  3. 2007 (1)
  4. 2005 (2)
  5. 2004 (1)
  6. 2003 (1)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Clinical Cancer Research (2)
  3. American Journal of Infection Control (1)
  4. Cancer (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (2)
  3. Elsevier Inc. (1)
  4. Wiley Blackwell (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Assessing effectiveness of first-line carboplatin, pemetrexed, and pembrolizumab in patients with recurrent/metastatic lung adenocarcinoma
    Meeting Abstract

    Ip, A.; Gutierrez, M.; Warren, M. E.; Pfister, D. G.; Brady, O.; Shen, R. L.; Riely, G. J.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Catheter associated urinary tract infection (CAUTI) surveillance: Less charts, more prevention
    Meeting Abstract

    Bell, N.; Eagan, J.; Warren, M.; Graham, J.; Kamboj, M.; Sepkowitz, K.
    American Journal of Infection Control (2015)

    Fulltext@MSK | Save
  • The association between measures of progression and survival in castrate-metastatic prostate cancer
    Journal Article

    Scher, H. I.; Warren, M.; Heller, G.
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Association of age, baseline characteristics, co-marbidity and toxicity in castrate metastatic prostate cancer patients (CMPC) treated with chemotherapy
    Meeting Abstract

    Fleming, M. T.; Beekman, K. W.; Warren, M.; Wilton, A.; Heller, G.; Scher, H.; Kelly, W. K.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Outcomes with second-line chemotherapy in castrate metastatic prostate cancer
    Meeting Abstract

    Beekman, K. W.; Fleming, M. T.; Scher, H. I.; Warren, M.; Ishill, N.; Heller, G.; Kelly, W. K.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma
    Journal Article

    Morris, M. J.; Smaletz, O.; Solit, D.; Kelly, W. K.; Slovin, S.; Flombaum, C.; Curley, T.; Delacruz, A.; Schwartz, L.; Fleisher, M.; more...
    Cancer (2004)

    Fulltext@MSK | Save
  • Dose escalation study of intravenous estramustine phosphate in combination with paclitaxel and carboplatin in patients with advanced prostate cancer
    Journal Article

    Kelly, W. K.; Zhu, A. X.; Scher, H.; Curley, T.; Fallon, M.; Slovin, S.; Schwartz, L.; Larson, S.; Tong, W.; Hartley-Asp, B.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Strategies to manage the adverse effects of oral morphine: An evidence-based report
    Journal Article

    Cherny, N.; Ripamonti, C.; Pereira, J.; Davis, C.; Fallon, M.; McQuay, H.; Mercadante, S.; Pasternak, G.; Ventafridda, V.
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save